NCT00978809

Brief Summary

The propose of this study is to compare two methods of physical treatment for benign paroxysmal positional vertigo, by evaluating treatment effects on postural stability. The trail design is a double blinded randomized controlled trail, with each patient going through three evaluations: before treatment, 1 week after treatment and 60 days after treatment.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2009

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2009

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

September 16, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 17, 2009

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2010

Completed
Last Updated

April 17, 2015

Status Verified

June 1, 2011

Enrollment Period

9 months

First QC Date

September 16, 2009

Last Update Submit

April 16, 2015

Conditions

Keywords

BPPVpostural stabilityEpleySemont

Outcome Measures

Primary Outcomes (1)

  • postural stability

    60 days post treatment

Secondary Outcomes (1)

  • subjective vertigo

    60 days post treatment

Study Arms (3)

Semont

ACTIVE COMPARATOR

BPPV patients treated by Semont maneuver by a physical therapist.

Other: Semont maneuver

control

NO INTERVENTION

healthy volunteers.

Epley maneuver

ACTIVE COMPARATOR

BPPV patients treated with Epley maneuver by a physical therapist.

Other: Epley maneuver

Interventions

Also known as: canalith repositioning maneuver
Epley maneuver
Also known as: liberatory manoeuvre
Semont

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • medical referral for treating "vertigo"
  • subject has short episodes of rotatory vertigo (up to 1 minute)
  • subject has positive Hallpike-Dix test with typical nystagmus
  • repeated Hallpike-dix test will show fatigability

You may not qualify if:

  • Hallpike-Dix test produces vertigo without nystagmus
  • subject has BPPV of the horizontal or anterior semi-circular canal
  • subject has other known vestibular or neurologic condition
  • subject has nystagmus of a different type
  • subject has a cervical spine problem which prevents the utilization of Epley or Semont maneuvers
  • subject is unable to stand for 1 minute
  • subject gets pharmacologic treatment for vertigo while doing the postural stability evaluation
  • subject is under 18 years old or a pregnant female or cannot obtain informed concent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maccabi health services

Beersheba, Israel

Location

Related Publications (2)

  • Blatt PJ, Georgakakis GA, Herdman SJ, Clendaniel RA, Tusa RJ. The effect of the canalith repositioning maneuver on resolving postural instability in patients with benign paroxysmal positional vertigo. Am J Otol. 2000 May;21(3):356-63. doi: 10.1016/s0196-0709(00)80045-9.

    PMID: 10821549BACKGROUND
  • Di Girolamo S, Paludetti G, Briglia G, Cosenza A, Santarelli R, Di Nardo W. Postural control in benign paroxysmal positional vertigo before and after recovery. Acta Otolaryngol. 1998 Jun;118(3):289-93. doi: 10.1080/00016489850183340.

    PMID: 9655200BACKGROUND

MeSH Terms

Conditions

Benign Paroxysmal Positional Vertigo

Condition Hierarchy (Ancestors)

VertigoVestibular DiseasesLabyrinth DiseasesEar DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Itshak Melzer, Dr

    Ben-Gurion University of the Negev

    STUDY CHAIR
  • Moshe Puterman, Dr

    Soroka University Medical Center

    STUDY DIRECTOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 16, 2009

First Posted

September 17, 2009

Study Start

September 1, 2009

Primary Completion

June 1, 2010

Study Completion

June 1, 2010

Last Updated

April 17, 2015

Record last verified: 2011-06

Locations